Katherine Goodrich
Director · 3 filings · Latest: Jun 25, 2026
Tarsus Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
TARS | Katherine Goodrich | Director | Jun 15, 2026 | Sale | $62.08 | 2,954 | $183.4K | 2,233 | |
TARS | Katherine Goodrich | Director | Jun 12, 2026 | Option Exercise | — | 2,954 | — | 5,187 | |
TARS | Goodrich Katherine | — | Jun 15, 2026 | Proposed Sale | $62.08 | 2,954 | $183.4K | — | |